Prosecution Insights
Last updated: April 19, 2026

LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

4 pending office actions

Portfolio Summary

4
Total Pending OAs
3
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18597711 ANTI-CD20 ANTIBODY COMPOSITIONS MIDDLETON, DANAYA L 1674 Final Rejection Mar 06, 2024
18597659 ANTI-CD20 ANTIBODY COMPOSITIONS MIDDLETON, DANAYA L 1674 Final Rejection Mar 06, 2024
18256801 NOVEL HUMAN ERYTHROID PROGENITOR CELL LINE HIGHLY PERMISSIVE TO B19 INFECTION AND USES THEREOF KNIGHT, TERESA E 1634 Non-Final OA Jun 09, 2023
17056626 Composition of Concentrated Human Immunoglobulins GAO, ASHLEY HARTMAN 1678 Final Rejection Nov 18, 2020

Managing LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month